Arbutus Biopharma Corp Net Asset Quality Index
Arbutus Biopharma Corp net asset quality index. Arbutus Biopharma Corp (ABUS) has a Net Asset Quality Index of 94.4% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $274.02 Million minus total liabilities of $15.29 Million yields net assets of $258.73 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check ABUS operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Arbutus Biopharma Corp (1998–2025)
Net asset quality index of Arbutus Biopharma Corp from 1998 to 2025. This chart shows how Arbutus Biopharma Corp's Net Asset Quality Index has evolved across 28 annual periods from 1998 to 2025. As of June 2026, the index stands at 94.4%, representing net assets of $258.73 Million against total assets of $274.02 Million USD. See Arbutus Biopharma Corp shareholders equity for net asset value and shareholders' equity analysis.
Arbutus Biopharma Corp Net Asset Quality Index by Year (1998–2025)
Arbutus Biopharma Corp net asset quality index by year from 1998 to 2025. The table below presents the year-by-year Net Asset Quality Index for Arbutus Biopharma Corp from 1998 to 2025, covering 28 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ABUS company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 80.9% | $76.58 Million | $94.62 Million | $18.04 Million | ▲ +7.0 pp |
| 2024 | 73.9% | $97.37 Million | $131.71 Million | $34.34 Million | ▲ +0.5 pp |
| 2023 | 73.4% | $106.02 Million | $144.40 Million | $38.38 Million | ▲ +3.4 pp |
| 2022 | 70.0% | $136.85 Million | $195.42 Million | $58.57 Million | ▼ -12.8 pp |
| 2021 | 82.9% | $169.44 Million | $204.49 Million | $35.05 Million | ▲ +8.5 pp |
| 2020 | 74.4% | $101.97 Million | $137.08 Million | $35.11 Million | ▲ +5.5 pp |
| 2019 | 68.9% | $72.74 Million | $105.53 Million | $32.79 Million | ▼ -18.9 pp |
| 2018 | 87.9% | $200.23 Million | $227.91 Million | $27.67 Million | ▲ +10.9 pp |
| 2017 | 76.9% | $182.50 Million | $237.20 Million | $54.70 Million | ▲ +3.4 pp |
| 2016 | 73.6% | $203.00 Million | $275.90 Million | $72.90 Million | ▼ -3.3 pp |
| 2015 | 76.9% | $547.68 Million | $712.29 Million | $164.61 Million | ▲ +2.4 pp |
| 2014 | 74.5% | $88.00 Million | $118.20 Million | $30.20 Million | ▼ -8.1 pp |
| 2013 | 82.5% | $59.19 Million | $71.72 Million | $12.52 Million | ▲ +4.7 pp |
| 2012 | 77.8% | $40.92 Million | $52.60 Million | $11.68 Million | ▲ +39.8 pp |
| 2011 | 38.0% | $5.21 Million | $13.70 Million | $8.50 Million | ▼ -13.1 pp |
| 2010 | 51.1% | $10.73 Million | $21.02 Million | $10.29 Million | ▼ -33.4 pp |
| 2009 | 84.5% | $35.44 Million | $41.95 Million | $6.51 Million | ▼ -5.9 pp |
| 2008 | 90.4% | $38.29 Million | $42.34 Million | $4.05 Million | ▲ +16.5 pp |
| 2007 | 74.0% | $18.37 Million | $24.83 Million | $6.46 Million | ▲ +71.4 pp |
| 2006 | 2.6% | $155.53K | $6.03 Million | $5.88 Million | ▲ +102.6 pp |
| 2005 | -100.0% | $-18.49 Million | $18.50 Million | $36.99 Million | ▼ -74.5 pp |
| 2004 | -25.5% | $-10.50 Million | $41.10 Million | $51.60 Million | ▼ -111.1 pp |
| 2003 | 85.5% | $43.38 Million | $50.73 Million | $7.35 Million | ▲ +0.3 pp |
| 2002 | 85.2% | $45.35 Million | $53.22 Million | $7.87 Million | ▼ -5.7 pp |
| 2001 | 91.0% | $61.49 Million | $67.60 Million | $6.12 Million | ▼ -1.4 pp |
| 2000 | 92.3% | $30.03 Million | $32.52 Million | $2.49 Million | ▼ -1.0 pp |
| 1999 | 93.3% | $26.88 Million | $28.80 Million | $1.92 Million | ▲ +2.2 pp |
| 1998 | 91.1% | $14.43 Million | $15.83 Million | $1.40 Million | — |